Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:deferasirox
|
| gptkbp:approvalYear |
2015
|
| gptkbp:associatedWith |
gptkb:Exjade
|
| gptkbp:ATCCode |
gptkb:V03AC03
|
| gptkbp:chemicalFormula |
C21H15N3O4
|
| gptkbp:contraindication |
severe renal impairment
hypersensitivity to deferasirox |
| gptkbp:form |
oral tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Jadenu
|
| gptkbp:indication |
transfusional iron overload
non-transfusion-dependent thalassemia syndromes |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting diarrhea abdominal pain increased serum creatinine |
| gptkbp:usedFor |
treatment of chronic iron overload
|
| gptkbp:bfsParent |
gptkb:deferasirox
|
| gptkbp:bfsLayer |
6
|